The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Procalcitonin Antibody Market Research Report 2024
Synopsis
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
The global Procalcitonin Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In China, Procalcitonin Antibody key players include Thermo Fisher, Wondfo , Ningbo Medicalsystem Biotechnology, bioMerieux, Snibe, etc. The top five players hold a share about 35%.
East China is the largest market, with a share about 25%, followed by South China and Southeast China, having a total share about 30 percent.
In terms of product, Monoclonal Procalcitonin Antibody is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital, followed by Medical research institutions, etc.
This report aims to provide a comprehensive presentation of the global market for Procalcitonin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin Antibody.
Report Scope
The Procalcitonin Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segment by Application
Hospital
Medical research institutions
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Procalcitonin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Procalcitonin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
The global Procalcitonin Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In China, Procalcitonin Antibody key players include Thermo Fisher, Wondfo , Ningbo Medicalsystem Biotechnology, bioMerieux, Snibe, etc. The top five players hold a share about 35%.
East China is the largest market, with a share about 25%, followed by South China and Southeast China, having a total share about 30 percent.
In terms of product, Monoclonal Procalcitonin Antibody is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital, followed by Medical research institutions, etc.
This report aims to provide a comprehensive presentation of the global market for Procalcitonin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin Antibody.
Report Scope
The Procalcitonin Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segment by Application
Hospital
Medical research institutions
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Procalcitonin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Procalcitonin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Procalcitonin Antibody Market Overview
1.1 Product Overview and Scope of Procalcitonin Antibody
1.2 Procalcitonin Antibody Segment by Type
1.2.1 Global Procalcitonin Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Polyclonal Procalcitonin Antibody
1.2.3 Monoclonal Procalcitonin Antibody
1.3 Procalcitonin Antibody Segment by Application
1.3.1 Global Procalcitonin Antibody Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Medical research institutions
1.3.4 Others
1.4 Global Procalcitonin Antibody Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin Antibody Revenue 2019-2030
1.4.2 Global Procalcitonin Antibody Sales 2019-2030
1.4.3 Global Procalcitonin Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Procalcitonin Antibody Market Competition by Manufacturers
2.1 Global Procalcitonin Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Procalcitonin Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Procalcitonin Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Procalcitonin Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Procalcitonin Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Procalcitonin Antibody, Product Type & Application
2.7 Procalcitonin Antibody Market Competitive Situation and Trends
2.7.1 Procalcitonin Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Procalcitonin Antibody Players Market Share by Revenue
2.7.3 Global Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Procalcitonin Antibody Retrospective Market Scenario by Region
3.1 Global Procalcitonin Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Procalcitonin Antibody Global Procalcitonin Antibody Sales by Region: 2019-2030
3.2.1 Global Procalcitonin Antibody Sales by Region: 2019-2024
3.2.2 Global Procalcitonin Antibody Sales by Region: 2025-2030
3.3 Global Procalcitonin Antibody Global Procalcitonin Antibody Revenue by Region: 2019-2030
3.3.1 Global Procalcitonin Antibody Revenue by Region: 2019-2024
3.3.2 Global Procalcitonin Antibody Revenue by Region: 2025-2030
3.4 North America Procalcitonin Antibody Market Facts & Figures by Country
3.4.1 North America Procalcitonin Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Procalcitonin Antibody Sales by Country (2019-2030)
3.4.3 North America Procalcitonin Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Procalcitonin Antibody Market Facts & Figures by Country
3.5.1 Europe Procalcitonin Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Procalcitonin Antibody Sales by Country (2019-2030)
3.5.3 Europe Procalcitonin Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procalcitonin Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Procalcitonin Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Procalcitonin Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Procalcitonin Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Procalcitonin Antibody Market Facts & Figures by Country
3.7.1 Latin America Procalcitonin Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Procalcitonin Antibody Sales by Country (2019-2030)
3.7.3 Latin America Procalcitonin Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procalcitonin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Procalcitonin Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Procalcitonin Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Procalcitonin Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Procalcitonin Antibody Sales by Type (2019-2030)
4.1.1 Global Procalcitonin Antibody Sales by Type (2019-2024)
4.1.2 Global Procalcitonin Antibody Sales by Type (2025-2030)
4.1.3 Global Procalcitonin Antibody Sales Market Share by Type (2019-2030)
4.2 Global Procalcitonin Antibody Revenue by Type (2019-2030)
4.2.1 Global Procalcitonin Antibody Revenue by Type (2019-2024)
4.2.2 Global Procalcitonin Antibody Revenue by Type (2025-2030)
4.2.3 Global Procalcitonin Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Procalcitonin Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Procalcitonin Antibody Sales by Application (2019-2030)
5.1.1 Global Procalcitonin Antibody Sales by Application (2019-2024)
5.1.2 Global Procalcitonin Antibody Sales by Application (2025-2030)
5.1.3 Global Procalcitonin Antibody Sales Market Share by Application (2019-2030)
5.2 Global Procalcitonin Antibody Revenue by Application (2019-2030)
5.2.1 Global Procalcitonin Antibody Revenue by Application (2019-2024)
5.2.2 Global Procalcitonin Antibody Revenue by Application (2025-2030)
5.2.3 Global Procalcitonin Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Procalcitonin Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Procalcitonin Antibody Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Corporation Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Diagnostics Procalcitonin Antibody Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Corporation Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 bioMerieux Procalcitonin Antibody Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Corporation Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HyTest Procalcitonin Antibody Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 Wondfo
6.5.1 Wondfo Corporation Information
6.5.2 Wondfo Description and Business Overview
6.5.3 Wondfo Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wondfo Procalcitonin Antibody Product Portfolio
6.5.5 Wondfo Recent Developments/Updates
6.6 Ningbo Medicalsystem Biotechnology
6.6.1 Ningbo Medicalsystem Biotechnology Corporation Information
6.6.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product Portfolio
6.6.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.7 Snibe
6.6.1 Snibe Corporation Information
6.6.2 Snibe Description and Business Overview
6.6.3 Snibe Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Snibe Procalcitonin Antibody Product Portfolio
6.7.5 Snibe Recent Developments/Updates
6.8 Vazyme Biotech
6.8.1 Vazyme Biotech Corporation Information
6.8.2 Vazyme Biotech Description and Business Overview
6.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vazyme Biotech Procalcitonin Antibody Product Portfolio
6.8.5 Vazyme Biotech Recent Developments/Updates
6.9 Getein Biotech
6.9.1 Getein Biotech Corporation Information
6.9.2 Getein Biotech Description and Business Overview
6.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Getein Biotech Procalcitonin Antibody Product Portfolio
6.9.5 Getein Biotech Recent Developments/Updates
6.10 Hotgen Biotech
6.10.1 Hotgen Biotech Corporation Information
6.10.2 Hotgen Biotech Description and Business Overview
6.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hotgen Biotech Procalcitonin Antibody Product Portfolio
6.10.5 Hotgen Biotech Recent Developments/Updates
6.11 Lumigenex
6.11.1 Lumigenex Corporation Information
6.11.2 Lumigenex Procalcitonin Antibody Description and Business Overview
6.11.3 Lumigenex Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lumigenex Procalcitonin Antibody Product Portfolio
6.11.5 Lumigenex Recent Developments/Updates
6.12 Shanghai Medicine'nest Pharmaceutical
6.12.1 Shanghai Medicine'nest Pharmaceutical Corporation Information
6.12.2 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Description and Business Overview
6.12.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product Portfolio
6.12.5 Shanghai Medicine'nest Pharmaceutical Recent Developments/Updates
6.13 Kitgen
6.13.1 Kitgen Corporation Information
6.13.2 Kitgen Procalcitonin Antibody Description and Business Overview
6.13.3 Kitgen Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kitgen Procalcitonin Antibody Product Portfolio
6.13.5 Kitgen Recent Developments/Updates
6.14 Beijing KeyGen
6.14.1 Beijing KeyGen Corporation Information
6.14.2 Beijing KeyGen Procalcitonin Antibody Description and Business Overview
6.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing KeyGen Procalcitonin Antibody Product Portfolio
6.14.5 Beijing KeyGen Recent Developments/Updates
6.15 Fantibody
6.15.1 Fantibody Corporation Information
6.15.2 Fantibody Procalcitonin Antibody Description and Business Overview
6.15.3 Fantibody Procalcitonin Antibody Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Fantibody Procalcitonin Antibody Product Portfolio
6.15.5 Fantibody Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procalcitonin Antibody Industry Chain Analysis
7.2 Procalcitonin Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procalcitonin Antibody Production Mode & Process
7.4 Procalcitonin Antibody Sales and Marketing
7.4.1 Procalcitonin Antibody Sales Channels
7.4.2 Procalcitonin Antibody Distributors
7.5 Procalcitonin Antibody Customers
8 Procalcitonin Antibody Market Dynamics
8.1 Procalcitonin Antibody Industry Trends
8.2 Procalcitonin Antibody Market Drivers
8.3 Procalcitonin Antibody Market Challenges
8.4 Procalcitonin Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
